Abstract
It has been shown recently that some analogues of clinically ineffective trans-diamminedichloroplatinum (II) (transplatin) exhibit antitumor activity. This finding has inverted the empirical structure-antitumor activity relationships delineated for platinum(II) complexes, according to which only the cis geometry of leaving ligands in the bifunctional platinum complexes is therapeutically active. As a result, interactions of trans platinum compounds with DNA, which is the main pharmacological target of platinum anticancer drugs, are of great interest. The present paper describes the DNA binding of antitumor trans-[PtCl(2)(E-imino ether)(2)] complex (trans-EE) in a cell-free medium, which has been investigated using three experimental approaches. They involve thiourea as a probe of monofunctional DNA adducts of platinum (II) complexes with two leaving ligands in the trans configuration, ethidium bromide as a probe for distinguishing between monofunctional and bifunctional DNA adducts of platinum complexes and HPLC analysis of the platinated DNA enzymatically digested to nucleosides. The results show that bifunctional trans-EE preferentially forms monofunctional adducts at guanine residues in double-helical DNA even when DNA is incubated with the platinum complex for a relatively long time (48 h at 37 degrees C in 10 mM NaCIO(4). It implies that antitumor trans-EE modifies DNA in a different way than clinically ineffective transplatin, which forms prevalent amount of bifunctional DNA adducts after 48 h. This result has been interpreted to mean that the major adduct of trans-EE, occurring in DNA even after long reaction times, is a monofunctional adduct in which the reactivity of the second leaving group is markedly reduced. It has been suggested that the different properties of the adducts formed on DNA by transplatin and trans-EE are relevant to their distinct clinical efficacy.
Full Text
The Full Text of this article is available as a PDF (91.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boudný V., Vrána O., Gaucheron F., Kleinwachter V., Leng M., Brabec V. Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes. Nucleic Acids Res. 1992 Jan 25;20(2):267–272. doi: 10.1093/nar/20.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brabec V., Kleinwächter V., Butour J. L., Johnson N. P. Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophys Chem. 1990 Apr;35(2-3):129–141. doi: 10.1016/0301-4622(90)80003-p. [DOI] [PubMed] [Google Scholar]
- Brabec V., Leng M. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5345–5349. doi: 10.1073/pnas.90.11.5345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brabec V., Síp M., Leng M. DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II). Biochemistry. 1993 Nov 2;32(43):11676–11681. doi: 10.1021/bi00094a025. [DOI] [PubMed] [Google Scholar]
- Butour J. L., Alvinerie P., Souchard J. P., Colson P., Houssier C., Johnson N. P. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2]. Eur J Biochem. 1991 Dec 18;202(3):975–980. doi: 10.1111/j.1432-1033.1991.tb16458.x. [DOI] [PubMed] [Google Scholar]
- Butour J. L., Macquet J. P. Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe. Eur J Biochem. 1977 Sep;78(2):455–463. doi: 10.1111/j.1432-1033.1977.tb11758.x. [DOI] [PubMed] [Google Scholar]
- Ciccarelli R. B., Solomon M. J., Varshavsky A., Lippard S. J. In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication. Biochemistry. 1985 Dec 17;24(26):7533–7540. doi: 10.1021/bi00347a005. [DOI] [PubMed] [Google Scholar]
- Coluccia M., Nassi A., Loseto F., Boccarelli A., Mariggio M. A., Giordano D., Intini F. P., Caputo P., Natile G. A trans-platinum complex showing higher antitumor activity than the cis congeners. J Med Chem. 1993 Feb 19;36(4):510–512. doi: 10.1021/jm00056a012. [DOI] [PubMed] [Google Scholar]
- Corda Y., Job C., Anin M. F., Leng M., Job D. Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry. 1991 Jan 8;30(1):222–230. doi: 10.1021/bi00215a032. [DOI] [PubMed] [Google Scholar]
- Eastman A., Barry M. A. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry. 1987 Jun 16;26(12):3303–3307. doi: 10.1021/bi00386a009. [DOI] [PubMed] [Google Scholar]
- Eastman A., Jennerwein M. M., Nagel D. L. Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II). Chem Biol Interact. 1988;67(1-2):71–80. doi: 10.1016/0009-2797(88)90087-7. [DOI] [PubMed] [Google Scholar]
- Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther. 1987;34(2):155–166. doi: 10.1016/0163-7258(87)90009-x. [DOI] [PubMed] [Google Scholar]
- Farrell N., Kelland L. R., Roberts J. D., Van Beusichem M. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. Cancer Res. 1992 Sep 15;52(18):5065–5072. [PubMed] [Google Scholar]
- Fichtinger-Schepman A. M., van der Veer J. L., den Hartog J. H., Lohman P. H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 1985 Jan 29;24(3):707–713. doi: 10.1021/bi00324a025. [DOI] [PubMed] [Google Scholar]
- Lemaire M. A., Schwartz A., Rahmouni A. R., Leng M. Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1982–1985. doi: 10.1073/pnas.88.5.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malinge J. M., Pérez C., Leng M. Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA. Nucleic Acids Res. 1994 Sep 25;22(19):3834–3839. doi: 10.1093/nar/22.19.3834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pinto A. L., Lippard S. J. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). Proc Natl Acad Sci U S A. 1985 Jul;82(14):4616–4619. doi: 10.1073/pnas.82.14.4616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts J. J., Friedlos F. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Cancer Res. 1987 Jan 1;47(1):31–36. [PubMed] [Google Scholar]
- Villani G., Hübscher U., Butour J. L. Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eucaryotic DNA polymerases alpha. Nucleic Acids Res. 1988 May 25;16(10):4407–4418. doi: 10.1093/nar/16.10.4407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zou Y., Van Houten B., Farrell N. Ligand effects on platinum binding to DNA. A comparison of DNA binding properties for cis- and trans-[PtCl2(amine)2] (amine = NH3, pyridine). Biochemistry. 1993 Sep 21;32(37):9632–9638. doi: 10.1021/bi00088a015. [DOI] [PubMed] [Google Scholar]